| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041038 |
| Receipt No. | R000043832 |
| Scientific Title | Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients |
| Date of disclosure of the study information | 2020/07/09 |
| Last modified on | 2020/07/09 (Ver. 1) |
| Basic information | ||
| Public title | Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients | |
| Acronym | Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients | |
| Scientific Title | Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients | |
| Scientific Title:Acronym | Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients | |
| Region |
|
|
| Condition | ||
| Condition | Respiratory disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To confirm the feeling of taking antibiotics of generic and generic products in pediatric patients and investigate the effect on medication adherence. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Medication adherence |
| Key secondary outcomes | Feeling of taking (ease of drinking, facial expression, ease of melting, smell, sweetness, bitterness) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | A simple randomized cross-over study was conducted using two drugs, one that had been adopted in the past (brand name A) and the other that had been adopted after the taste test (brand name B), and each drug was taken twice a day for two days. | |
| Interventions/Control_2 | At the end of each dose, sweetness, bitterness, odor, solubility (index I-IV), and ease of taking the drug were assessed in five levels, and ease of taking were analyzed by multiple regression analysis with ease of taking as the objective variable. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients 3 years of age or older who were seen in our pediatric outpatient clinic between April 1, 2018 and March 31, 2020, and for whom CAM-DS was prescribed and who are considered to have a taste complaint. | |||
| Key exclusion criteria | Patients who are unable to take their medication or for whom parental consent could not be obtained | |||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Mitoyo General Hospital | ||||||
| Division name | Pharmaceutical department | ||||||
| Zip code | 769-1695 | ||||||
| Address | 708 Himehama,Toyohama-cho,Kan-onji-city,Kagawa,JAPAN | ||||||
| TEL | 0875-52-3366 | ||||||
| shino-ph@mitoyo-hosp.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Mitoyo General Hospital | ||||||
| Division name | Pharmaceutical department | ||||||
| Zip code | 769-1695 | ||||||
| Address | 708 Himehama,Toyohama-cho,Kan-onji-city,Kagawa,JAPAN | ||||||
| TEL | 0875-52-3366 | ||||||
| Homepage URL | |||||||
| shino-ph@mitoyo-hosp.jp | |||||||
| Sponsor | |
| Institute | Mitoyo General Hospital
Pharmaceutical department |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Mitoyo General Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Clinical Research Review Committee of Mitoyo General Hospital |
| Address | 708 Himehama,Toyohama-cho,Kan-onji-city,Kagawa,JAPAN |
| Tel | 0875-52-3366 |
| shino-ph@mitoyo-hosp.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 17CR01-057 |
| Org. issuing International ID_1 | Clinical Research Review Committee of Mitoyo General Hospital |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 三豊総合病院(香川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 19 | ||||||
| Results | The mean dosing status score for brand name A was 18.1 and for generic B was 19.3. Multiple regression analysis revealed that the standard regression coefficients for the original drug A were I - 0.34, II 0.51, III 0.47, and IV 0. 26. (All NS) For generic B, the coefficients were I-0.07, II-1.08, III-0.42, and IV-0.28. (NS for I, p<0.01 for II and III, and p<0.05 for IV) The mean score for ease of drinking was A2 for the branded drug. .26 and generic B3.05. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043832 |